Announcements Trials
Browse Landscape

Phase

Phase 1 61Phase 2 40Phase 1/2 14Phase 3 12Phase NA 2Phase 4 2Phase 2/3 2Phase EARLY_PHASE1 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Ovarian Neoplasms 7Lung Neoplasms 5Central Nervous System Neoplasms 5Retinoblastoma 4Neuroblastoma 4Uterine Cervical Neoplasms 3Fallopian Tube Neoplasms 3Breast Neoplasms 3Testicular Neoplasms 2Spinal Cord Neoplasms 2Small Cell Lung Carcinoma 2Oligodendroglioma 2Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma 2Endometrial Neoplasms 2Dendritic Cell Sarcoma, Interdigitating 2Brain Neoplasms 2Adenocarcinoma of Lung 2Waldenstrom Macroglobulinemia 1Vomiting 1Triple Negative Breast Neoplasms 1Teratoma 1Stage IA Uterine Sarcoma 1Solid Tumor Cancer 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1

Interventions

Exercise 83Standard of Care 45Blood Specimen Collection 43Methods 32Therapeutics 28Surveys and Questionnaires 27Educational Status 25Control Groups 20Cognitive Behavioral Therapy 20Interviews as Topic 18Music Therapy 15Biopsy 15Acupuncture Therapy 15Palliative Care 14Resistance Training 13Magnetic Resonance Spectroscopy 13Early Intervention, Educational 13Radiotherapy 10Radiosurgery 10Nutrition Assessment 9Behavior Therapy 9Yoga 8Psychiatric Rehabilitation 8Practice Guidelines as Topic 8Patient Navigation 8Counseling 8Ultraviolet Therapy 7Physical Therapy Modalities 7Nutritional Status 7Mindfulness 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Neoplasms × Carboplatin × Clear all
NCT06363708 2024-04-12

Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer

Zhongnan Hospital

Phase NA Not yet recruiting
20 enrolled
Gynecologic

Neoplasms, Endometrial Neoplasms

NCT00145028 2009-03-18

Determination of Carboplatin's Optimal Plasmatic Exposure

Institut Claudius Regaud

Phase NA Completed
400 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡